These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 17900853)
1. Transdermal buprenorphine may be effective in the treatment of pruritus in primary biliary cirrhosis. Reddy L; Krajnik M; Zylicz Z J Pain Symptom Manage; 2007 Nov; 34(5):455-6. PubMed ID: 17900853 [No Abstract] [Full Text] [Related]
2. Intravenous naloxone plus transdermal buprenorphine in cancer pain associated with intractable cholestatic pruritus. Marinangeli F; Guetti C; Angeletti C; Bonetti C; Paladini A; Piroli A; Varrassi G J Pain Symptom Manage; 2009 Oct; 38(4):e5-8. PubMed ID: 19699606 [No Abstract] [Full Text] [Related]
3. Transdermal buprenorphine (Butrans) for chronic pain. Med Lett Drugs Ther; 2011 Apr; 53(1362):31-2. PubMed ID: 21502936 [TBL] [Abstract][Full Text] [Related]
4. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study. Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474 [TBL] [Abstract][Full Text] [Related]
5. Transdermal buprenorphine for the treatment of chronic noncancer pain in the oldest old. Gianni W; Madaio AR; Ceci M; Benincasa E; Conati G; Franchi F; Galetti G; Nieddu A; Salani B; Zuccaro SM J Pain Symptom Manage; 2011 Apr; 41(4):707-14. PubMed ID: 21145700 [TBL] [Abstract][Full Text] [Related]
6. Oropharyngeal mucositis pain treatment with transdermal buprenorphine in patients after allogeneic stem cell transplantation. Vokurka S; Skardova J; Karas M; Kostkova J; Steinerova K; Koza V; Bystricka E J Pain Symptom Manage; 2010 Jun; 39(6):e4-6. PubMed ID: 20538178 [No Abstract] [Full Text] [Related]
7. Pruritus and fatigue in primary biliary cirrhosis. Bergasa NV; Mehlman JK; Jones EA Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):643-55. PubMed ID: 10976020 [TBL] [Abstract][Full Text] [Related]
9. Transdermal buprenorphine for the treatment of moderate to severe chronic pain: results from a large multicenter, non-interventional post-marketing study in Poland. Przeklasa-Muszynska A; Dobrogowski J Curr Med Res Opin; 2011 Jun; 27(6):1109-17. PubMed ID: 21456888 [TBL] [Abstract][Full Text] [Related]
10. Successful treatment of pruritus with topical tacrolimus in a patient with primary biliary cirrhosis. Aguilar-Bernier M; Bassas-Vila J; Sanz-Munoz C; Miranda-Romero A Br J Dermatol; 2005 Apr; 152(4):808-9. PubMed ID: 15840123 [No Abstract] [Full Text] [Related]
11. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison. Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542 [TBL] [Abstract][Full Text] [Related]
12. Transdermal buprenorphine in pain management--experiences from clinical practice: Five case studies. Louis F Int J Clin Pract; 2006 Oct; 60(10):1330-4. PubMed ID: 16981980 [TBL] [Abstract][Full Text] [Related]